Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pharvaris N.V. (NQ: PHVS )

17.21 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 17.21
Bid (Size) 6.890 (2)
Ask (Size) 27.53 (2)
Prev. Close 17.21
Today's Range 17.21 - 17.21
52wk Range 1.770 - 26.86
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pharvaris to Present at the GA²LEN UCARE Conference 2023
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
From Pharvaris N.V.
Via GlobeNewswire

Performance

YTD
+43.06%
+43.06%
1 Month
+1.18%
+1.18%
3 Month
-16.05%
-16.05%
6 Month
+90.38%
+90.38%
1 Year
+715.64%
+715.64%

More News

Read More
Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting
From Pharvaris N.V.
Via GlobeNewswire
8 Analysts Have This to Say About Pharvaris
Via Benzinga
Analyst Expectations for Pharvaris's Future
Via Benzinga
Why Shares of Pharvaris N.V. Are Up Tuesday
Via The Motley Fool
Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris To Present at the ACAAI 2023 Annual Scientific Meeting
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris To Present at the APAAACI 2023 International Conference
From Pharvaris N.V.
Via GlobeNewswire
5 Analysts Have This to Say About Pharvaris
Via Benzinga
Pharvaris To Present at the CIIC Fall 2023 Conference
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris' Promising Oral Treatment Solutions For Treating Swollen Blood Vessels - Analyst Sees 35% Upside
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
Pharvaris To Participate in the 2023 Cantor Global Healthcare Conference
From Pharvaris N.V.
Via GlobeNewswire
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Pharvaris To Present at the 18th German Allergy Congress
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris To Present at the 2023 HAEi Regional Conference EMEA
From Pharvaris N.V.
Via GlobeNewswire
Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
Via Benzinga
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris Presents Clinical Data at the 2023 U.S. HAEA National Summit
From Pharvaris N.V.
Via GlobeNewswire
FDA Removes Clinical Hold Of Pharvaris' Deucrictibant For On-Demand Treatment Of HAE
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.